Coexpression of NRP1 and NRP2 also increases in the progression from dysplasia to microinvasive lung carcinoma, and correlates significantly with tumour progression and poor prognosis in patients with non-small-cell lung carcinoma (Kawakami et al, 2002). Here, NRP1 is linked to lung carcinoma.